USFDA authorizes Moderna COVID vaccine booster shots for all adults Ruchika Sharma20 Nov 2021 3:43 PM ISTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has recently announced that the U.S....
Patient Zero: New Study Identifies the 1st identified COVID-19 case MD Bureau20 Nov 2021 10:35 AM ISTAs per the study, the patient Zero was a female seafood vendor at an animal market in the Chinese city of Wuhan and who became symptomatic on December...
Bharat Biotech says developing Covaxin was big challenge MD Bureau19 Nov 2021 1:00 PM ISTBengaluru: Bharat Biotech Director, V. Krishna Mohan, has said developing the Covaxin in "just 10 months" was an enormous challenge. Addressing...
SII, Novavax get emergency use nod for COVID vaccine in Philippines Ruchika Sharma18 Nov 2021 12:51 PM ISTPune: Novavax, Inc. and Serum Institute of India Pvt. Ltd. (SII) have recently announced that the Philippine Food and Drug Administration (FDA)...
Dr Reddys open to making Pfizer COVID pill after deal with Merck Roshni Dhar18 Nov 2021 10:57 AM ISTDr. Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was...
Health Bulletin 17/November/2021 Roshni Dhar17 Nov 2021 4:29 PM ISTHere are Top Health Stories of the dayMedical College Should be Welfare State: Gujarat HC over Bond Amount DisputeObserving that a medical college,...
Pfizer, Medicines Patent Pool ink pact to expand Covid-19 oral antiviral treatment access Ruchika Sharma17 Nov 2021 11:00 AM ISTNew York: Pfizer Inc. and the Medicines Patent Pool (MPP), have recently announced the signing of a voluntary license agreement for Pfizer's...
Phase 3 data shows Covaxin 77.8 percent effective against COVID: Lancet Roshni Dhar16 Nov 2021 4:05 PM ISTBharat Biotech has recently announced that the safety and efficacy analysis data from Phase III clinical trials of COVAXIN is peer reviewed and...
Covaxin has cellular immune memory to COVID for at least 6 months: NII Ruchika Sharma16 Nov 2021 1:21 PM ISTNew Delhi: Bharat Biotech's Covaxin has immunological memory to Covid and its variants of concern for at least up to six months, National...
Serum Institute allowed to export 5 crore Covovax doses to Indonesia Ruchika Sharma16 Nov 2021 11:00 AM ISTNew Delhi: The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum...
AstraZeneca begins to earn mild profit from Covid-19 vaccine Ruchika Sharma15 Nov 2021 3:37 PM ISTNew Delhi: AstraZeneca said it would begin to earn a modest profit from its coronavirus vaccine as the world learns to live with the virus and the...
Zydus Cadila ZyCov-D to be administered only to adults: Report Ruchika Sharma15 Nov 2021 3:33 PM ISTNew Delhi: Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be...
